On 2026-03-23, Xilio Therapeutics, Inc. (XLO) announced earnings per share of $-0.85 for the fiscal quarter ending 2025-12-31, beating the average analyst estimate of $-1.68.
The next expected annoucement date for quarterly earnings is 2026-05-14, with an average estimated earnings per share of $-0.66 for the fiscal quarter ending 2026-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-03-23 | 2025-12-31 | $-1.68 | $-0.85 |
| 2025-11-13 | 2025-09-30 | $-0.42 | $-0.42 |
| 2025-08-14 | 2025-06-30 | $-1.12 | $-2.24 |
| 2025-05-08 | 2025-03-31 | $1.40 | $-2.52 |
| 2025-03-11 | 2024-12-31 | $-3.08 | $-2.80 |
| 2024-11-07 | 2024-09-30 | $-3.50 | $-3.08 |
| 2024-08-08 | 2024-06-30 | $-3.22 | $-3.36 |
| 2024-05-14 | 2024-03-31 | $-4.20 | $-8.26 |
| 2024-04-01 | 2023-12-31 | -- | $-8.96 |
| 2023-11-09 | 2023-09-30 | $-10.64 | $-8.54 |
| 2023-08-14 | 2023-06-30 | $-11.76 | $-9.80 |
| 2023-05-09 | 2023-03-31 | $-12.75 | $-11.62 |
| 2023-03-02 | 2022-12-31 | $-11.62 | $-11.48 |
| 2022-11-09 | 2022-09-30 | $-12.46 | $-10.08 |
| 2022-08-09 | 2022-06-30 | $-10.92 | $-12.61 |
| 2022-05-12 | 2022-03-31 | $-14.01 | $-10.92 |
| 2022-03-01 | 2021-12-31 | $-13.17 | $-13.73 |
| 2021-12-02 | 2021-09-30 | $-28.01 | $-297.90 |